tryptophan has been researched along with Heart Failure in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ge, J; Gong, X; Huang, Z; Liang, Y; Qin, S; Shao, W; Su, Y; Sun, Z; Yu, Z; Zheng, Y; Zhou, Q | 1 |
| Alcaide, P; Anastasiou, M; Aronovitz, M; Carrillo-Salinas, FJ; Jetton, D; Kaur, K; Ngwenyama, N; Smolgovsky, SA; Tai, A | 1 |
| Andrade, A; Andrade, JP; Barbosa, J; Gonçalves, VMF; Leal, S; Peixoto, B; Ribeiro, C; Silva, P; Sousa, A | 1 |
| Alonso-Gómez, A; Aros, F; Clish, CB; Corella, D; Dennis, C; Estruch, R; Fiol, M; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hernández-Alonso, P; Hu, FB; Lapetra, J; Li, J; Liang, L; Martínez-González, MA; Razquin, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wittenbecher, C | 1 |
| Eschenhagen, T; Foo, RS; Geertz, B; Hirt, MN; Höppner, G; Löser, A; Ng, SL; Peters, BS; Reichenspurner, H; Schaefer, A; Schneeberger, Y; Stenzig, J; Tan, W; Wong, E; Zhao, RR | 1 |
| Chen, YH; Chou, CH; Ho, YL; Huang, CC; Hung, CS; Kuo, CC; Lee, CM; Lin, YH; Liu, LD; Wu, KK; Yeh, JF | 1 |
| Huang, WL; Liu, XW; Yang, CJ; Yang, J; Yang, Y; Zeng, P | 1 |
| Kuo, CC; Lin, YH; Wu, KK | 1 |
| Akaishi, M; Baba, A; Ito, H; Kurita, Y; Matsubara, T; Monkawa, T; Nagatomo, Y; Naito, K; Nakamura, I; Ogawa, S; Wakabayashi, Y; Yoshikawa, T; Yoshizawa, A | 1 |
| Janicki, JS; Law, BA; Levick, SP; Li, J; Meléndez, GC; Supowit, SC | 1 |
| Fuchs, D; Schroecksnadel, K; Wirleitner, B | 1 |
| Heliö, T; Jääskeläinen, P; Kaartinen, M; Kärkkäinen, S; Kuusisto, J; Laakso, M; Miettinen, R; Nieminen, MS; Peuhkurinen, K; Reissell, E; Toivonen, L; Tuomainen, P; Ylitalo, K | 1 |
| Hartmann, C; McIntire, WS | 1 |
| Auzépy, P; Grosgogeat, Y; Leguillant, F; Manigand, G; Sarrazin, A | 1 |
1 trial(s) available for tryptophan and Heart Failure
| Article | Year |
|---|---|
Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Diet, Mediterranean; Female; Heart Failure; Humans; Kynurenine; Logistic Models; Male; Metabolomics; Middle Aged; Prospective Studies; Risk Factors; Tryptophan | 2021 |
13 other study(ies) available for tryptophan and Heart Failure
| Article | Year |
|---|---|
Circulating metabolite profiles to predict response to cardiac resynchronization therapy.
Topics: Aged; Biomarkers; Cardiac Resynchronization Therapy; Chromatography, High Pressure Liquid; Female; Heart Failure; Humans; Isoleucine; Linoleic Acid; Male; Mass Spectrometry; Metabolomics; Middle Aged; Predictive Value of Tests; Recovery of Function; Severity of Illness Index; Treatment Outcome; Tryptophan | 2020 |
Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Disease Models, Animal; Dysbiosis; Endomyocardial Fibrosis; Fatty Acids, Volatile; Gastrointestinal Microbiome; Heart Failure; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Inflammation; Lymphocyte Activation; Lymphocyte Depletion; Male; Mice; Mice, Inbred C57BL; Receptors, Aryl Hydrocarbon; T-Lymphocytes; Tryptophan; Ventricular Pressure; Ventricular Remodeling | 2020 |
Development and validation of a liquid chromatography method using UV/fluorescence detection for the quantitative determination of metabolites of the kynurenine pathway in human urine: Application to patients with heart failure.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Heart Failure; Humans; Kynurenine; Male; Pilot Projects; Tryptophan | 2021 |
Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats.
Topics: Analysis of Variance; Animals; Cardiomegaly; CpG Islands; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Fibrosis; Gene Expression Regulation; Heart Failure; Magnetic Resonance Imaging; Male; Myocardium; Myocytes, Cardiac; Phthalimides; Rats; Rats, Wistar; Sequence Analysis, RNA; Thoracic Arteries; Tryptophan; Ventricular Function | 2018 |
5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility.
Topics: Aged; Biomarkers; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Prognosis; Prospective Studies; ROC Curve; ST Elevation Myocardial Infarction; Time Factors; Tryptophan; Ventricular Remodeling | 2016 |
5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure.
Topics: Heart Failure; Humans; Myocardial Infarction; Tryptophan | 2017 |
Reply to letter: "5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure".
Topics: Heart Failure; Humans; Myocardial Infarction; Tryptophan | 2017 |
Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy.
Topics: Adult; Aged; Amino Acid Sequence; Cardiomyopathy, Dilated; Female; Heart Failure; Humans; Immunoglobulin G; Immunosorbent Techniques; Male; Middle Aged; Molecular Sequence Data; Natriuretic Peptide, Brain; Tryptophan; Ventricular Function, Left | 2011 |
Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.
Topics: Animals; Apoptosis; Cell Degranulation; Collagen; Disease Models, Animal; Heart Failure; In Situ Nick-End Labeling; Male; Mast Cells; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Neurokinin A; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Time Factors; Tryptophan; Tumor Necrosis Factor-alpha; Ultrasonography; Ventricular Remodeling | 2011 |
Anemia and congestive heart failure.
Topics: Anemia; Causality; Cell Division; Chronic Disease; Comorbidity; Dioxygenases; Heart Failure; Hematopoiesis; Hemoglobins; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Kynurenine; Neopterin; Oxygenases; Prevalence; Tryptophan | 2003 |
Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy.
Topics: Adolescent; Adult; Aged; Arginine; Blood Pressure; Cardiomyopathy, Dilated; Child; Female; Finland; Follow-Up Studies; Genetic Predisposition to Disease; Glutamine; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Mutation; Myosin Heavy Chains; Pedigree; Phenotype; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Sarcomeres; Stroke Volume; Tropomyosin; Troponin C; Troponin I; Troponin T; Tryptophan; Ventricular Myosins | 2004 |
Amine-oxidizing quinoproteins.
Topics: Amino Acid Sequence; Coenzymes; Copper; Diabetes Mellitus; Dihydroxyphenylalanine; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Heart Failure; Humans; Indolequinones; Liver Cirrhosis; Lysine; Menkes Kinky Hair Syndrome; Metalloproteins; Mixed Function Oxygenases; Models, Molecular; Molecular Sequence Data; Oxidation-Reduction; Oxidoreductases Acting on CH-NH Group Donors; PQQ Cofactor; Protein-Lysine 6-Oxidase; Quinolones; Quinones; Semicarbazides; Sequence Homology, Amino Acid; Spectrum Analysis, Raman; Stereoisomerism; Substrate Specificity; Tryptophan | 1997 |
[Alcoholic myocardiopathies. Clinical study].
Topics: Adult; Alcoholism; Atrial Fibrillation; Cardiomegaly; Cardiomyopathies; Diagnosis, Differential; Electrocardiography; Female; Heart Diseases; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Prognosis; Tryptophan; Xanthurenates | 1969 |